Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Metabolic FDG-PET imaging in breast cancer: implications for treatment stratification

Nature Clinical Practice Oncology volume 4, pages 336–337 (2007)Cite this article

boxed-textRousseau C et al. (2006) Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 24: 5366–5372

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Avril N et al. (2000) Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 18: 3495–3502

    Article  CAS  Google Scholar 

  2. Wahl RL et al. (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11: 2101–2111

    Article  CAS  Google Scholar 

  3. Avril NE and Weber WA (2005) Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am 43: 189–204

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Nuclear Medicine, Barts and The London School of Medicine, West Smithfield (QE II), London EC1A 7BE, UK n.e.avril@qmul.ac.uk

Authors and Affiliations

  1. N Avril is the Director of the PET Centre at Barts and The London School of Medicine, Queen Mary College, University of London, London, UK.,

    Norbert Avril

Authors
  1. Norbert Avril
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avril, N. Metabolic FDG-PET imaging in breast cancer: implications for treatment stratification. Nat Rev Clin Oncol 4, 336–337 (2007). https://doi.org/10.1038/ncponc0817

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0817

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing